Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
Patent 6613322 Issued on September 2, 2003. Estimated Expiration Date: March 3, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
The present invention provides for a method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitor effective to decrease extracellular zinc sphingomyelinase activity in the subject and thereby treat the subject. The present invention also provides for a method for determining whether a compound inhibits an activity of an extracellular zinc sphingomyelinase involving ceramide formation which comprises: (a) contacting a sample containing zinc sphingomyelinase under acidic pH conditions known to be associated with the activity of such zinc sphingomyelinase, with: (i) a substrate of the zinc sphingomyelinase enzyme, and (ii) the compound being evaluated; (b) measuring the ceramide in the sample from (a); (c) determining the amount of zinc sphingomyelinase activity in the sample based on the concentration of ceramide measured in step (b); and (d) comparing the amount of sphingomyelinase activity determined in step (c) with the amount of sphingomyelinase activity determined in the absence of the compound, so as to determine whether the compound inhibits the activity of zinc sphingomyelinase.
Schissel et al. J. Biol. Chem. vol. 273, No. 5, pp. 2738-2746, Caplus abstract enclosed, 1998.
Faust, P.L., Wall, D.A., Perara, E., Lingappa, V.R., and Kornfeld, S. (1987) J. Biol. Chem. 269, 22477-22480
Hannun, Y. A. and R. M. Bell. 1989. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243:500-507
Kolesnick, R. N. 1991. Sphingomyelin and derivatives as cellular signals. Prog. Lipid Res. 30:1-38
Levade, T., Salvayre, R., and Blazy-Douste, L. (1986) J. Clin. Chem. Biochem. 24, 205-220
Okwu, A. K., X. Xu, Y. Shiratori, and I. Tabas. 1994. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content. J. Lipid Res. 35:644-655
Schissel, S. L., E. H. Schuchman, K. J. Williams, and I. Tabas. 1996. Zn2+ -stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem
Schissel, S. L., Schuchman, E. H., Williams, K. J., and Tabas, I. (1996) J. Biol. Chem. 271, 18431-18436
Schissel, S. L., J. Tweedie-Hardman, J. H. Rapp, G. Graham, K. J. Williams, and I. Tabas. 1996. Rabbit aorta and human atherosclerotic lesions hydolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98:1455-1464
Schuchman, E. H., M. Suchi, T. Takahashi, K. Sandhoff, and R. J. Desnick. 1991. Human acid sphingomyelinase. Isolation, nucleotide sequence, and expression of the full-length and alternatively spliced cDNAs. J. Biol. Chem. 266:8531-8539
Skiba, P. J., X. Zha, S. L. Schissel, F. R. Maxfield, and I. Tabas. 1996. The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent. J. Biol. Chem. 271:13392-13400
Spence, M. W., D. M. Byers, F. B. St.C.Palmer, and H. W. Cook. 1989. A new Zn2+ -stimulated sphingomyelinase in fetal bovine serum. J. Biol. Chem. 264:5358-5363
Tabas, I., Y. Li, R. W. Brocia, S. W. Wu, T. L. Swenson, and K. J. Williams. 1993. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J. Biol. Chem. 268:20419-20432
Williams, K. J., G. M. Fless, K. A. Petrie, M. L. Snyder, R. W. Brocia, and T. L. Swenson. 1992. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267:13284-13292
Williams, K. J. and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:551-561
Xu, X. and I. Tabas. 1991. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J. Biol. Chem. 266:24849-24858